It also remains to be determined if the APOL1 association with OI in the settings of HIV infection extends to other settings of immune suppression (e.g., individuals with nephrotic syndrome or chronic and end-stage kidney disease experiencing uremia, or transplant recipients and cancer patients taking immunosuppressive drugs). This evidence concerns the gene APOL1 and HIV infectious disease.